SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Article
[키워드] Alter
antibodies
antibody
B.1.1.7
B.1.351
bamlanivimab
blockade
Brazil
camostat
Casirivimab
cell interaction
convalescent COVID-19 patient
COVID-19
COVID-19 pandemic
effort
Entry inhibitor
escape
health system
host cell
Host cell entry
human cell
implication
individuals
inhibited
inhibitor
less
Mutation
neutralization
neutralizing antibody
neutralizing antibody responses
P.1
P.1 variant
pandemic
plasma
Protein
pseudoparticles
recombinant
SARS-CoV-2
SARS-CoV-2 variant
sera
soluble ACE2
South Africa
Spike protein
Spread
susceptible
Treatment
variant
variants
variants of concern
viral spike
VoC
[DOI] 10.1016/j.cell.2021.03.036 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cell.2021.03.036 PMC 바로가기 [Article Type] Article